Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant

Medicine and Dentistry

• Antiestrogen 100%
• Promoter Region 66%
• Tamoxifen 66%
• Fulvestrant 66%
• Gene Expression 50%
• Breast Cancer 50%
• DNA Methylation 50%
• Hormone 33%
• Growth 33%
• Cells 33%
• Comprehension 33%
• Receptor 16%
• Estrogen 16%
• Cancer Cell 16%
• Phenotype 16%
• Upregulation 16%
• Estrogen Receptor 16%
• Combination Therapy 16%
• Hybridization 16%
• Microarray Analysis 16%
• Gene Control 16%
• Development 16%
• Methylation 16%
• CpG Island 16%
• Introspection 16%
• Adaptation 16%
• Drug 16%
• Chemotherapeutic Agent 16%
• Gene 16%
• Targeted Therapy 16%
• Human Genome 16%
• Gene Silencing 16%

Neuroscience

• Antiestrogen 100%
• Promoter Region 66%
• Tamoxifen 66%
• Fulvestrant 66%
• Gene Expression 50%
• DNA Methylation 50%
• Eicosanoid Receptor 16%
• Phenotype 16%
• Estrogen Receptor 16%
• Estrogens 16%
• Gene Inactivation 16%
• Gene Control 16%
• Methylation 16%
• CpG Island 16%
• Gene 16%
• Microarray 16%

Biochemistry, Genetics and Molecular Biology

• Fulvestrant 66%
• Promoter Region 50%
• Gene Expression 50%
• DNA Methylation 50%
• Growth 33%
• Comprehension 33%
• Cancer Cell 16%
• Nested Gene 16%
• Upregulation 16%
• Phenotype 16%
• Estrogen Receptor 16%
• Gene Control 16%
• Hybridization 16%
• Methylation 16%
• Development 16%
• Adaptation 16%
• CpG Island 16%
• Introspection 16%
• Human Genome 16%
• Microarray 16%